Epigral (BOM:543332) Total Liabilities : ₹15,402 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Epigral Total Liabilities?

Epigral's Total Liabilities for the quarter that ended in Mar. 2024 was ₹15,402 Mil.

Epigral's quarterly Total Liabilities declined from Sep. 2023 (₹15,198.84 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹15,402.41 Mil).

Epigral's annual Total Liabilities declined from Mar. 2022 (₹13,976.97 Mil) to Mar. 2023 (₹13,631.35 Mil) but then increased from Mar. 2023 (₹13,631.35 Mil) to Mar. 2024 (₹15,402.41 Mil).

Epigral Total Liabilities Historical Data

The historical data trend for Epigral's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Total Liabilities Chart

Epigral Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

6,899.91

7,645.68

13,976.97

13,631.35

15,402.41

Epigral Quarterly Data
	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial											13,631.35	-	15,198.84	-	15,402.41

Epigral Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Epigral's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7795.741	+	(5471.353	+	2135.315
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	15,402

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	27943.416	-	12541.007
	=	15,402

Epigral's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7795.741	+	(5471.353	+	2135.315
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	15,402

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	27943.416	-	12541.007
	=	15,402

Epigral Total Liabilities Related Terms

Thank you for viewing the detailed overview of Epigral's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigral (BOM:543332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (BOM:543332) » Definitions » Total Liabilities

Traded in Other Exchanges

EPIGRAL:India

Address

Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.meghmanifinechem.com

Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (BOM:543332) Headlines

No Headlines